Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
Conditions
Advanced Clear Cell Renal Cell Carcinoma · Metastatic Clear Cell Renal Cell Carcinoma · Stage III Renal Cell Cancer AJCC v8 · Stage IV Renal Cell Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
City of Hope National Medical Center, Duarte, California, United States
Contact: Principal Investigator (Sumantra Pal, MD)Chao Family Comprehensive Cancer Center, Orange, California, United States
Contact: Principal Investigator (Nataliya Mar, MD)University Hospitals Seidman Cancer Center, Cleveland, Ohio, United States
Contact: Principal Investigator (Pedro Barata, MD)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Moshe Ornstein, MD)Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Study coordinator (Vanderbilt-Ingram Service for Timely Access) · cip@vumc.org · 800-811-8480Contact: Principal Investigator (Brian I. Rini, MD)University of Texas, Southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Vanderbilt-Ingram Services for Timely Access) · cip@vumc.org · 800-811-8480Contact: Principal Investigator (Tian Zhang, MD)
Study leads
Brian I Rini, MD
Principal Investigator
Vanderbilt University/Ingram Cancer Center